Support The Moscow Times!

Russia’s Coronavirus Vaccine Delivers Immunity After First Dose – Developer

Russia has seen a growing number of daily Covid-19 infections in September. Alexander Zemlianichenko Jr / AP / TASS

Russia’s Sputnik V coronavirus vaccine confers immunity among some recipients after the first shot, its developer has said in an interview with state media Friday.

Sputnik V is an adenovirus-based vector vaccine that is administered in two doses. President Vladimir Putin last month hailed it as the world’s first registered coronavirus vaccine, though large-scale trials to prove its safety and effectiveness have only recently started in Moscow and small batches are being distributed across Russian regions.

Alexander Gintsburg, the head of Moscow’s state-run Gamaleya research institute that developed Sputnik V, told the RIA Novosti news agency that developing immunity for Covid-19 depends on individual reactions to both the vaccine and the infection.

“For some, the protective level of antibodies is produced after the first vaccination and they need the second one to extend that protection. They will likely be protected two weeks after the first vaccination,” he said.

Gintsburg noted that while no volunteers have become infected between the two shots, he did not rule out that risk.  

“If there is [an infection between the first and second shots], it will occur in a weaker form,” he said.

There are “no grounds” for vaccine recipients to self-isolate or limit contacts, Gintsburg added.

Gintsburg, 68, has said he received the adenoviral vector-based vaccine himself. Previously, the microbiologist noted that booster shots for Sputnik V would be required every two years.

Russia has seen a growing number of daily Covid-19 infections in September following two months of new cases falling below 5,000. On Friday, Russia confirmed more than 7,000 new infections for the first time since late June.

Officials maintain that Russia is still battling its first wave of the virus, not the second.

Overall, the country has the world’s fourth-highest number of infections at 1.13 million.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more